Related Experiment Videos
Antitumor activity of three mouse mammary cancer cell lines after interferon-gamma gene transfection
Y L Matory1, M Chen, D M Dorfman
1Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass 02115, USA.
Background:
The antitumor effects of three mouse mammary tumors transfected to express interferon-gamma were evaluated.
Methods:
Three immunologically different tumors were used: DA3, EMT6, and 410. All three cell lines were successfully transfected with highly efficient viral vectors. Wild type or transfected tumor cells were injected subcutaneously into Balb/c mice. Animals were observed for tumor growth and the induction of immunologic memory.
Results:
A significant decrease occurred in the size of all transfected tumors, EMT6 1.9 cm2, DA3 1.7, and 410 1.8 compared with nontransfected control tumors with a mean size of 4 cm2 on day 30. To further test the development of immunity, animals were injected with either nontransfected or transfected tumors and challenged with nontransfected tumor. Animals immunized with transfected tumor cells had significantly smaller tumors, EMT6 2.5 cm2, DA3 3.1, and 410 2.4 compared with controls with a mean size of 4 cm2. No specific splenocyte cytotoxicity was shown. Expression of major histocompatibility complex class I antigens was enhanced in the 410 and DA3 tumor lines.
Conclusions:
Significant antitumor effects were observed after interferon-gamma gene transfection of three mouse mammary cancer cell lines. Up-regulation of major histocompatibility complex class I antigen expression is a partial explanation of these findings. These results provide preliminary studies for gene therapy of human breast cancer.
Insights
Gene therapy using interferon-gamma successfully reduced mouse mammary tumor size. Transfected tumors showed significant antitumor effects and induced immunologic memory, suggesting potential for human breast cancer treatment.
Area of Science:
- Immunology
- Oncology
- Gene Therapy
Background:
- Interferon-gamma (IFN-γ) plays a crucial role in immune responses.
- Mammary tumors are a significant health concern in both mice and humans.
- Evaluating novel therapeutic strategies for cancer is essential.
Purpose of the Study:
- To assess the antitumor efficacy of mouse mammary tumors engineered to express interferon-gamma.
- To investigate the induction of immunologic memory following treatment with transfected tumor cells.
- To explore the potential of gene therapy for breast cancer treatment.
Main Methods:
- Three distinct mouse mammary tumor cell lines (DA3, EMT6, 410) were transfected with viral vectors to express IFN-γ.
- Subcutaneous injection of wild-type or transfected tumor cells into Balb/c mice.
- Monitoring tumor growth, induction of immunologic memory, and major histocompatibility complex (MHC) class I antigen expression.
Main Results:
- Transfected tumors exhibited a significant reduction in size compared to control tumors (1.7–1.9 cm² vs. 4 cm² at day 30).
- Mice immunized with transfected cells showed smaller tumors upon challenge, indicating induced immunologic memory.
- Enhanced expression of MHC class I antigens was observed in DA3 and 410 transfected tumor lines.
Conclusions:
- Interferon-gamma gene transfection demonstrated significant antitumor effects in mouse mammary cancer models.
- Up-regulation of MHC class I antigens contributes to the observed antitumor activity.
- These findings support the preliminary investigation of gene therapy for human breast cancer.